1. Home
  2. MLYS vs FMNB Comparison

MLYS vs FMNB Comparison

Compare MLYS & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$28.68

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Farmers National Banc Corp.

FMNB

Farmers National Banc Corp.

HOLD

Current Price

$15.94

Market Cap

857.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
FMNB
Founded
2019
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
857.4M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
MLYS
FMNB
Price
$28.68
$15.94
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
$48.67
$15.00
AVG Volume (30 Days)
1.1M
320.7K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
4.89%
EPS Growth
37.43
18.85
EPS
N/A
0.76
Revenue
N/A
$279,922,000.00
Revenue This Year
N/A
$52.63
Revenue Next Year
N/A
$8.28
P/E Ratio
N/A
$21.00
Revenue Growth
N/A
3.89
52 Week Low
$22.30
$12.23
52 Week High
$47.65
$16.46

Technical Indicators

Market Signals
Indicator
MLYS
FMNB
Relative Strength Index (RSI) 56.53 52.96
Support Level $25.56 $15.43
Resistance Level $31.26 $16.15
Average True Range (ATR) 1.54 0.27
MACD 0.27 -0.02
Stochastic Oscillator 56.63 61.45

Price Performance

Historical Comparison
MLYS
FMNB

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a financial holding company based in the U.S. Along with its subsidiaries, it operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The group offers a full range of commercial and retail banking services, including checking accounts, savings accounts, time deposit accounts, commercial, mortgage, and installment loans, safe deposit boxes, ATMs, internet banking, and other banking services. Additionally, it offers personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; insurance products, and other financial products and services. The group's reportable segments are Bank, which generates the maximum revenue, and Trust.

Share on Social Networks: